Adial Pharmaceuticals, Inc. (ADIL)
Company Info
| ISIN | US00688A1060 |
|---|---|
| CUSIP | 00688A106 |
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | $2.61M |
|---|---|
| EPS | -$8.98 |
| PE Ratio | 0.02 |
| EBITDA (TTM) | -$10.15M |
| Year Range | $1.82 - $15.00 |
| Target Price | $17.00 |
| Short % | 4.77% |
| Short Ratio | 2.24 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of $10,000 in Adial Pharmaceuticals, Inc., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Return
Adial Pharmaceuticals, Inc. had a return of -60.56% year-to-date (YTD) and -70.51% in the last 12 months.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -60.56% | 18.75% |
| 1 month | 0.47% | 8.90% |
| 6 months | -69.16% | 8.42% |
| 1 year | -70.51% | 13.21% |
| 5 years (annualized) | -42.39% | 11.63% |
| 10 years (annualized) | N/A | 9.74% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | -1.57% | -23.66% | -20.84% | 54.18% | -45.42% | -36.53% | -30.58% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Adial Pharmaceuticals, Inc. (ADIL) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
ADIL Adial Pharmaceuticals, Inc. | -0.48 | ||||
^GSPC S&P 500 | 0.98 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below displays the maximum drawdowns of the Adial Pharmaceuticals, Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Adial Pharmaceuticals, Inc. was 99.07%, occurring on Oct 31, 2023. The portfolio has not yet recovered.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.07% | Jan 16, 2019 | 1207 | Oct 31, 2023 | — | — | — |
| -71.53% | Aug 2, 2018 | 74 | Nov 14, 2018 | 25 | Dec 21, 2018 | 99 |
| -18.86% | Dec 27, 2018 | 3 | Dec 31, 2018 | 1 | Jan 2, 2019 | 4 |
| -11.11% | Jan 4, 2019 | 2 | Jan 7, 2019 | 3 | Jan 10, 2019 | 5 |
| -1.23% | Jul 30, 2018 | 2 | Jul 31, 2018 | 1 | Aug 1, 2018 | 3 |
Volatility Chart
The current Adial Pharmaceuticals, Inc. volatility is 26.62%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.